radiotherapy major therapeutic non lung cancer development conformal radiotherapy NUMBER authorized dose escalation occur concomitant association chemotherapy delivered acceptable toxicities multimodal therapeutic sequences investigated integrating new techniques irradiation intensity modulation allows superior dose escalation increased focalisation ballistics stereotactic radiotherapy radiotherapy available europe time indicated exclusive treatment tumors patients improvements possible sequential concurrent association radiotherapy chemotherapy regimens gemcitabine requiring dose adaptation improving systemic tumor control regarding optimization chemoradiation need reevaluate knowledge treatment locally advanced non lung cancer launching multimodal therapeutic strategies including radiotherapy chemotherapy surgery developments make radiotherapy promising therapeutics thoracic oncology references NUMBER small cell dimensional proton beam early stage non operable new generation small cell